Scholars Central

Research articlePublished 23 Aug 2018

Development and Validation of Stability Indicating Rp-Uflc Method for The Estimation of Linagliptin in Active Pharmaceutical Ingredients

Authors: R. Maruthi, R.S. Chandan, Anand Kumar Tengli

Research & Reviews: Journal of Pharmaceutical Analysis

Volume 7 · Issue 1 · Pages 12–23

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A simple, RP-UFLC method was established for determining Linagliptin in Active Pharmaceutical Ingredients. Linagliptin is a DPP-4 inhibitor developed by BoehringerIngelheim (German Pharmaceutical Company) for treatment of type II diabetes. Linagliptin was approved by the US FDA on 2 May 2011 for treatment of type II diabetes. Linagliptin and their degradation products were separated using C18 column with Acetonitrile: Methanol (50:50 (v/v) as the mobile phase. Detection was performed at 238 nm using a PDA detector and flow rate 1.5 ml/min and retention time was 4.4 min respectively. The method was validated using ICH guidelines and was linear in the range 2-10 μg /ml (r2=0.995) for Linagliptin. The method showed good linearity, accuracy, precision, ruggedness, robustness, and specificity. Good separation of the analytes and their degradation products was achieved using this method. The developed method can be applied successfully for the determination of Linagliptin. The present method was validated with respect to system suitability, accuracy (recovery) precision, linearity, limit of detection (LOD) and limit of quantification (LOQ) and robustness according to the ICH Guidelines.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Research & Reviews: Journal of Pharmaceutical Analysis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalResearch & Reviews: Journal of Pharmaceutical Analysis
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “R. Maruthi”
  • BylineArticles whose byline prints “R.S. Chandan”
  • BylineArticles whose byline prints “Anand Kumar Tengli”